The malaria antidote
Mint tracks the progress of global research in evolving a malaria vaccine and the success in creating drugs to tackle similar killer diseases
In a major scientific breakthrough, the world is on the threshold of creating a vaccine to prevent malaria—which causes 1.2 million deaths globally every year. British drug maker GlaxoSmithKline Plc. has sought marketing approval for the world’s first malaria vaccine after clinical trials conducted in Burkina Faso, Africa, showed the shot significantly cut cases of the disease in African children. Mint takes stock of the progress of global research in evolving a malaria vaccine and also tracks the success in creating vaccines to tackle similar killer diseases.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!